• No results found

GnRH agonists

Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT

Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT

... a GnRH agonist. The aim of pretreatment with GnRH agonist is to avoid spontaneous luteinizing hormone surge and subsequent ...without GnRH agonist pretreatment and reported similar clinical outcomes ...

8

GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down regulation

GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down regulation

... cavity. GnRH agonists exhibit anti-proliferative and apoptosis-enhancing activities and have long been used for the treatment of ...involving GnRH agonist therapy for the treatment of ...after ...

10

GnRH Agonists: Are They Ready for Clinical Use as an Anti-adhesive Agent? A Review of the Literature

GnRH Agonists: Are They Ready for Clinical Use as an Anti-adhesive Agent? A Review of the Literature

... groups, GnRH agonists achieve better adhesion severity and extension ...When GnRH agonists and antagonists come in comparison, the first ones are characterised by better adhesion extension and ...

10

Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis

<p>Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis</p>

... between GnRH agonists and antagonists was de fi ned as the presence of a GnRH agonist/antagonist type of therapy during follow-up period different than that prescribed at ...of GnRH agonist ...

9

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial

... regarding GnRH ad- ministration in the luteal phase showed that the implant- ation rate, the clinical pregnancy rate (CPR) per transfer and the ongoing pregnancy rate were significantly higher in the group of ...

6

GnRH analogs for the treatment of symptomatic uterine leiomyomas

GnRH analogs for the treatment of symptomatic uterine leiomyomas

... by GnRH agonist treatment [36] should be due to a relative vasoconstriction of myoma- tous vessels [37, 38] and/or to diminished nitric oxide production ...with GnRH-a compared with those receiving placebo ...

7

Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders

Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders

... of GnRH agonists, ...of GnRH agonist, and observed higher cancellation rates, lower clinical preg- nancies and decreased numbers of oocytes re- trieved per cycle with the microdose flare-up regi- men ...

7

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

... 7). GnRH antagonists have several advantages over GnRH ...with GnRH agonist protocols ...in GnRH agonists and GnRH antagonists groups ...of GnRH antagonists based on the ...

7

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

... Introduction: We sought to address whether there are clinical responses when patients who are failing gonadotropin releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation therapy ...

16

PubMedCentral-PMC4960458.pdf

PubMedCentral-PMC4960458.pdf

... all GnRH agonists. Each GnRH agonist regimen was dose standardized by converting each instance of GnRH agonist in use on separate days to a monthly dosing ...prescribe GnRH ...

16

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

... of GnRH analo- gues, a surge in LH occurs after approximately 20% of all IVF cycles/intracytoplasmic sperm injections (ICSI) ...increased. GnRH agonists (GnRH-a) have been used in assisted ...

10

Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis

Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis

... of GnRH agonists for prevention of chemotherapy- induced ovarian damage in premenopausal women with breast ...of GnRH agonists for prevention of ovarian ...

11

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

... (GnRH) agonists have been successfully used for the last 20 years ...of GnRH agonists, which can prevent premature luteinization and then significantly reduce the cycle cancellation rate via ...

7

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist

... LH. GnRH specifi- cally activates GnRH receptors on LH-producing cells in the pituitary and stimulates endogenous LH production and release, which in turn acts on the gonads to increase sex steroid ...

9

Gonadotropin releasing hormone receptor mRNA expression by human pituitary tumors in vitro

Gonadotropin releasing hormone receptor mRNA expression by human pituitary tumors in vitro

... An important question in the pathogenesis and regulation of human gonadotroph adenomas is whether heterogeneous gonadotropin responses to gonadotropin-releasing hormone (GnRH) are due to dysregulation of ...

9

Decreased FGF8 signaling causes deficiency of gonadotropin releasing hormone in humans and mice

Decreased FGF8 signaling causes deficiency of gonadotropin releasing hormone in humans and mice

... in GnRH neuronal ...their GnRH neurons (37) and Fgf8 hypomorphic mice exhibit a decrease in the number of, or the absence of, GnRH neurons in the ...their GnRH neuron status in ...

11

Effects of decreasing the frequency of gonadotropin releasing hormone stimulation on gonadotropin secretion in gonadotropin releasing hormone deficient men and perifused rat pituitary cells

Effects of decreasing the frequency of gonadotropin releasing hormone stimulation on gonadotropin secretion in gonadotropin releasing hormone deficient men and perifused rat pituitary cells

... isolated GnRH deficiency who had achieved normal sex steroid levels during prior long-term pulsatile GnRH replacement and (b) perifused dispersed pituitary cells from male rats in the absence of sex ...four ...

10

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

... All patients recruited to this study were stimulated using the long luteal GnRH agonist protocol [12]. Trip- torelin (Decapeptyl, Ipsen, Slough, United Kingdom) at a daily dose of 0.1 mg/S.C was started one week ...

8

Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis

Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis

... The initiation of mammalian puberty and the maintenance of female reproductive cycles are events controlled by hypothalamic neurons that secrete the decapeptide gonadotropin-releasing hormone (GnRH). GnRH ...

11

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

... in GnRH-ant cycles, are still a matter of ...by GnRH-a administration is likely to be detrimental for the follicle- oocyte ...in GnRH-ant regimens was ...at GnRH- ant initiation, or from ...

8

Show all 840 documents...

Related subjects